digital therapeutics founder startup support 
TechCrunch
SEPTEMBER 9, 2021
Neuroglee Therapeutics , a startup developing digital therapeutics for people with neurodegenerative diseases, has raised a $10 million Series A led by Openspace Ventures and EDBI. The funding will be used to launch virtual neurology clinics and to support Neuroglee’s move to Boston. Neuroglee gets $2.3
TechCrunch
DECEMBER 3, 2020
Alzheimer’s is the leading cause of dementia and caregivers are often overwhelmed, without enough support. Neuroglee , a Singapore-based health tech startup, wants to help with a digital therapeutic platform created to treat patients in the early stages of the disease. million in pre-seed funding.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
TechCrunch
MAY 12, 2023
A recent survey by TechCrunch+ indicates that investors and founders are, instead of simply looking for attractive opportunities, increasingly putting their minds to building the foundations for an industry that can employ the power of psychedelics to change lives.
TechCrunch
JULY 11, 2022
For Amanda D’Ambra and Joan Zhang, the idea of starting and co-founding an eating disorder care startup was personal: Both struggled with an eating disorder, along with other mental health issues, and received treatment — a treatment they hope more people will be able to access.
TechCrunch
NOVEMBER 3, 2021
As the world’s population ages, more is being learned about brain health as startups leverage technology to find a way to slow down cognitive impairment. This startup just raised $8 million to help busy doctors assess the cognitive health of 50 million seniors.
TechCrunch
JULY 8, 2022
Moving Analytics founders and undergraduate friends Harsh Vathsangam and Shuo Qiao met their third co-founder, Ade Adesanya, at the University of Southern California. Moving Analytics founders outside their Irvine office. Left to right: Joe Villanueva, Ade Adesanya, Harsh Vathsangam, Shuo Qiao. Image Credits: Moving Analytics.
Angel Capital Association
MAY 18, 2020
Hans Christian Andersen wrote these words nearly 200 years ago, but a bold new startup is living proof of music’s inherent ability to stimulate, and even heal, the human brain. Maine Venture Fund (MVF), a group of angels that belong to ACA, invested in MedRhythms, alongside several individuals, family funds, and Maine Technology Institute.
Expert insights. Personalized for you.
93 
Let's personalize your content